T. Rowe Price Investment Management
T. Rowe Price Investment Management reported 694 stocks worth $142B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are MSFT (3.6%), AMZN (2.9%) and NVDA (2.7%). Compared with Q2 2026, the fund opened new positions in BSP and FIX, added to NVDA, AMD and AAPL, trimmed MSFT, AMZN and META and sold out of TXT, BAH and PWR.
Latest filing: what T. Rowe Price Investment Management did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() MSFT Microsoft Corp | $5.1B | 3.6% | 9.9M | −713K (−7%) | 8 of 8 | |
| 2 | ![]() AMZN Amazon Com Inc | $4.1B | 2.9% | 16.5M | −94K (−1%) | 8 of 8 | |
| 3 | ![]() NVDA Nvidia Corporation | $3.9B | 2.7% | 16.9M | +66K (+0%) | 8 of 8 | |
| 4 | ![]() AMD Advanced Micro Devices Inc | $3B | 2.1% | 5M | +1.1M (+29%) | 8 of 8 | |
| 5 | ![]() AAPL Apple Inc | $2.7B | 1.9% | 8.1M | +593K (+8%) | 8 of 8 | |
| 6 | ![]() CNP Centerpoint Energy Inc | $2.5B | 1.7% | 67.2M | +760K (+1%) | 8 of 8 | |
| 7 | ![]() ALNY Alnylam Pharmaceuticals Inc | $2.5B | 1.7% | 10M | +4.4M (+77%) | 8 of 8 | |
| 8 | ![]() META Meta Platforms Inc | $2.4B | 1.7% | 3.3M | −1.4M (−29%) | 8 of 8 | |
| 9 | ![]() COR Cencora Inc | $2B | 1.4% | 6.6M | −762K (−10%) | 8 of 8 | |
| 10 | ![]() ASND Ascendis Pharma A/s | $1.9B | 1.3% | 8.2M | +1.4M (+21%) | 3 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
![]() TXT Textron Inc | $400M | 4.4M |
![]() BAH Booz Allen Hamilton Hldg Cor | $262M | 4.3M |
![]() PWR Quanta Svcs Inc | $206M | 286K |
![]() RAL Ralliant Corp | $156M | 2.1M |
![]() RVMD Revolution Medicines Inc | $109M | 579K |
🔒 Free account: see all 30.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 16, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →T. Rowe Price Investment Management 13F FAQ
What does T. Rowe Price Investment Management own?
T. Rowe Price Investment Management reported 694 stocks worth $142B in its 13F filing for Q3 2026, filed Nov 16, 2026. The table above lists every position in the filing (the top 10 without an account).
What did T. Rowe Price Investment Management buy and sell in Q3 2026?
Compared with Q2 2026: 62 new positions, 289 added to, 338 trimmed and 104 sold out. New positions include BSP and FIX. It sold all of TXT, BAH and PWR.
When will T. Rowe Price Investment Management file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is T. Rowe Price Investment Management's portfolio worth?
The Q3 2026 filing reports $142B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.























